Evidence map›Paper›PMID 42543259›Full record

Trial reportAddiction (Abingdon, England)2026

Promoting smoking cessation and preventing relapse to tobacco use following a smokefree mental health in-patient stay: A multi-centre randomised controlled feasibility study.

Petal Petersen Williams, Lisa Huddlestone, Emily Shoesmith, Jennifer Sweetman, Heidi Stevens, Alex Mitchell, Fraser Wiggins, Lesley Sinclair, Victoria Exley, Catherine Hewitt and 11 more

Abstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Addiction (Abingdon, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Trial
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Petal Petersen WilliamsMental Health and Addiction Research Group, Department of Health Sciences, University of York, York, UK.ORCID https://orcid.org/0000-0001-5535-2458
Lisa HuddlestoneMental Health and Addiction Research Group, Department of Health Sciences, University of York, York, UK.ORCID https://orcid.org/0000-0002-8054-4475
Emily ShoesmithMental Health and Addiction Research Group, Department of Health Sciences, University of York, York, UK.ORCID https://orcid.org/0000-0002-2420-4919
Jennifer SweetmanMental Health and Addiction Research Group, Department of Health Sciences, University of York, York, UK.
Heidi StevensMental Health and Addiction Research Group, Department of Health Sciences, University of York, York, UK.
Alex MitchellYork Trials Unit, Department of Health Sciences, University of York, York, UK.
Fraser WigginsYork Trials Unit, Department of Health Sciences, University of York, York, UK.
Lesley SinclairYork Trials Unit, Department of Health Sciences, University of York, York, UK.
Victoria ExleyYork Trials Unit, Department of Health Sciences, University of York, York, UK.
Catherine HewittYork Trials Unit, Department of Health Sciences, University of York, York, UK.
Judith WatsonYork Trials Unit, Department of Health Sciences, University of York, York, UK.
Qi WuYork Trials Unit, Department of Health Sciences, University of York, York, UK.ORCID https://orcid.org/0000-0002-8281-7799
Jodi PervinMental Health and Addiction Research Group, Department of Health Sciences, University of York, York, UK.
Moira LeahyResearch Development Unit, Sheffield Health Partnership University NHS Foundation Trust, Sheffield, UK.
Claire PaulResearch and Development, Leeds and York Partnership NHS Foundation Trust, Leeds, UK.
Lion ShahabInstitute for Epidemiology and Health Care, University College London, London, UK.ORCID https://orcid.org/0000-0003-4033-442X
Michelle HorspoolResearch Development Unit, Sheffield Health Partnership University NHS Foundation Trust, Sheffield, UK.
Tim ColemanCentre for Academic Primary Care, University of Nottingham, Nottingham, UK.ORCID https://orcid.org/0000-0002-7303-4805
Simon HoughIndependent PPI Co-applicant, Cheshire, UK.
Elena RatschenMental Health and Addiction Research Group, Department of Health Sciences, University of York, York, UK.ORCID https://orcid.org/0000-0003-4128-9608
SCEPTRE Collaboration team

Funding

National Institute for Health and Care Research NIHR200607
6 · The paper itself

Abstract

aimsThis study assessed the feasibility and acceptability of a new theory- and evidence-based intervention designed to prevent return to pre-admission smoking behaviours after discharge from a smokefree mental health in-patient setting in the United Kingdom (UK).

designA multi-centre individually randomised controlled feasibility trial with follow-up at 3 and 4-6 months.

settingAcute adult mental health wards of six National Health Service Mental Health Trusts in England.

participantsThirty-eight (17 intervention, 21 usual care) adults who smoked on or after admission to an acute adult mental health in-patient ward and wished to continue reducing or quitting smoking after discharge, enrolled between February and November 2024.

interventionThe intervention comprised usual care and a 12-week, theory- and evidence-informed support programme including a bespoke resource kit, personalised behavioural support including phone calls and text messages, and access to a digital smoking cessation app with 24/7 live support. It was delivered by trained mental health workers. The comparator group received usual care as per UK national guidance, typically involving brief behavioural support, offers of nicotine replacement therapy and sometimes electronic cigarettes. MEASUREMENT: Primary outcomes included recruitment and retention, intervention acceptability and feasibility of collecting smoking, mental health and economic data. Success criteria for progression to trial were set a priori at a minimum of 60% of the n = 64 target for both recruitment and retention, i.e. at n = 38. Secondary outcomes included measures of smoking, quitting, reduction of cigarette consumption. Acceptability data were collected through exploratory interviews with participants, mental health staff and interventionists.

findingsWe recruited n = 38 (60%) participants and retained n = 20 (52.6%) at 3 months, and n = 13 (34.2%) at second follow-up. As such, criteria agreed to determine progression to full trial were marginally met for recruitment and not met for retention. Two intervention participants reported maintaining abstinence. Motivation to quit remained higher in the intervention than the usual care group over time, and use of e-cigarettes was overall common (76.9% n = 10 across groups at 4-6 month follow up). Intervention group participants reported valuing the tailored and personalised behavioural support options but engaged little with tailored digital tools. Health economic data collection was feasible, though refinement is needed for future research.

conclusionsA new intervention delivering smoking cessation support to individuals discharged from smoke-free mental health settings was discontinued because key feasibility criteria were not met, highlighting the need for focused reconsideration of recruitment and retention strategies, intervention design and delivery in mental health in-patient populations. Design implications are discussed, taking into account individual patient-level and systemic challenges.

Indexed as

Mental DisordersSecondary PreventionSmoking CessationAdherence InterventionsAdultEnglandFeasibility StudiesFemaleHumansMaleMiddle AgedNicotine Replacement TherapyUnited Kingdomfeasibilityin‐patientmental healthsmokingsmoking cessationtobacco dependence

Identifiers

PMID42543259
PMCPMC13677810

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.